Evidence map›Paper›PMID 42357634›Full record

ArticleViruses2026

A qPCR-Based Screening Platform for Exploratory Assessment of Phage Training Outcomes in

Ghadeer Jdeed, Vera Morozova, Valeria Fedorets, Tatiana Ushakova, Lina Al Allaf, Igor Babkin, Nina Tikunova

Abstract read
In one paragraph

Article in Viruses, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ghadeer JdeedLaboratory for Molecular Microbiology, Institute of Chemical Biology and Fundamental Medicine SB RAS, 630090 Novosibirsk, Russia.ORCID 0000-0003-2907-1155
Vera MorozovaLaboratory for Molecular Microbiology, Institute of Chemical Biology and Fundamental Medicine SB RAS, 630090 Novosibirsk, Russia.ORCID 0000-0002-0869-3476
Valeria FedoretsLaboratory for Molecular Microbiology, Institute of Chemical Biology and Fundamental Medicine SB RAS, 630090 Novosibirsk, Russia.ORCID 0009-0000-2070-6332
Tatiana UshakovaLaboratory for Molecular Microbiology, Institute of Chemical Biology and Fundamental Medicine SB RAS, 630090 Novosibirsk, Russia.
Lina Al AllafLaboratory for Molecular Microbiology, Institute of Chemical Biology and Fundamental Medicine SB RAS, 630090 Novosibirsk, Russia.ORCID 0000-0003-0981-7722
Igor BabkinLaboratory for Molecular Microbiology, Institute of Chemical Biology and Fundamental Medicine SB RAS, 630090 Novosibirsk, Russia.
Nina TikunovaLaboratory for Molecular Microbiology, Institute of Chemical Biology and Fundamental Medicine SB RAS, 630090 Novosibirsk, Russia.

Funding

Russian Science Foundation 25-64-00030
6 · The paper itself

Abstract

Bacteriophages (phages) represent promising therapeutic agents. Their clinical use is challenged by the rapid rise of resistant bacterial clones. To overcome this problem, phages can be trained in vitro to improve their ability to cope with the possible resistance that may arise. Here, we co-evolved phages with their hosts under different conditions and assessed their ability to infect an adapted bacterial panel using qPCR. The co-evolution experiment yielded a panel of bacterial clones adapted either to a phage, a competing phage, or a cocktail of both. Phages were adapted either in the continuous presence of an evolutionarily naïve host, in a cocktail with a competing phage, under both conditions, or under neither condition. We assessed each resulting phage for its ability to infect evolved bacterial clones in the panel we created, using qPCR for preliminary high-throughput assessment. This allowed us to evaluate 500 phages-bacteria interactions. Overall, qPCR-detected phage production following infection of different bacterial clones improved to varying degrees when evolutionary naïve hosts were added during the training. However, the screening suggests that optimal training conditions are phage-specific. For

Indexed as

BacteriophagesEnterobacter cloacaeReal-Time Polymerase Chain ReactionStenotrophomonas maltophiliabacteriophageco-evolutionexperimental evolutionhigh-throughput screeninghost-range expansionphage cocktailsphage therapyphage trainingqPCRreal-time PCR

Identifiers

PMID42357634
PMCPMC13307863

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.